山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (2): 67-72.doi: 10.6040/j.issn.1673-3770.0.2016.425

• 论著 • 上一篇    下一篇

姜黄素联合白藜芦醇抑制人头颈部肿瘤细胞系增殖的机制研究

周华群1,张立庆1,徐朝琪2,姜盼2,王愿1,刘晓静1,董伟达1   

  1. 1. 南京医科大学第一附属医院/江苏省人民医院耳鼻咽喉科, 江苏 南京 210029;
    2. 南京医科大学公共卫生学院营养与食品卫生学系, 江苏 南京 211166
  • 收稿日期:2016-10-09 出版日期:2017-04-16 发布日期:2017-04-16
  • 通讯作者: 董伟达. E-mail:weidadong2649@126.com
  • 基金资助:
    江苏省卫生计生委面上课题(编号H201603)

Curcumin combined with resveratrol enhances their anti-tumoral effects in the head and neck carcinoma.

  1. 1.Department of Otorhinolaryngology, First Affiliated Hospital of Nanjing Medical University/Jiangsu Provincial Peoples Hospital, Nanjing 210029, Jiangsu, China;2.Department of Nutrition and Food Hygiene, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, China
  • Received:2016-10-09 Online:2017-04-16 Published:2017-04-16

PDF (PC)

666

被引次数

1

摘要： 目的 探讨姜黄素联合白藜芦醇抑制人头颈部肿瘤细胞系增殖的机制。 方法 用姜黄素和白藜芦醇联合处理Hep2(人喉癌细胞株)及FaDu(人下咽癌细胞株),应用MTT(塞唑蓝)比色法检测细胞增殖抑制率,平板克隆增殖实验检测单个细胞集落形成能力,Hoechst33258染色检测细胞凋亡情况,同时应用Real-time PCR法检测Bax和Bcl-2 的mRNA 表达水平。 结果 姜黄素和白藜芦醇对Hep2和FaDu细胞增殖有抑制作用,二者联合处理后,对细胞增殖、细胞克隆形成能力及细胞凋亡的抑制均明显增强;同时,姜黄素和白藜芦醇上调细胞中Bax和下调Bcl-2的mRNA水平。 结论 姜黄素与白藜芦醇联合处理可抑制Hep2及FaDu细胞增殖,作用机制可能与上调Bax、下调Bcl-2基因表达有关。

关键词: 白藜芦醇, 增殖, 姜黄素, FaDu细胞, Hep2细胞, 凋亡

Abstract: Objective To study the effect of curcumin in combination of resveratrol on proliferation in the head and neck neoplasm cell lines. Methods Hep2 cells and FaDu cells were treated with Curcumin and resveratrol. MTT was used to determine cell proliferation. Colony formation was used to detect the cell viability. Hoechst 33258 staining was performed to observe the cell apoptosis. The mRNA expressions of Bax and Bcl-2 were analyzed by Real-time PCR. Results Hep2 and FaDu cell proliferation could be inhibited with curcumin and resveratrol in a dose-dependent manner. Their combination exhibited the best inhibitory effects. Curcumin combined with resveratrol exhibited colony repression and showed a more significant apoptosis in Hep2 and FaDu cells. Real-time PCR demonstrated that Bax mRNA was upregulated and Bcl-2 mRNA was downregulated by curcumin and resveratrol. Meanwhile, Bax mRNA was upregulated and Bcl-2 mRNA was downregulated by curcumin and resveratrol. Conclusion The combination of curcumin and resveratrol can inhibit the proliferation of Hep2 and FaDu cells more significantly. The potential mechanism may be related with the up-regulation of Bax and the down-regulation of Bcl-2.

Key words: Proliferation, Curcumin, Resveratrol, Hep2 cells, FaDu cells, Apoptosis

中图分类号: 

  • R739.91
[1] Parkin DM, Pisani P, Ferlay J. Global cancer statistics[J]. CA Cancer Clin, 1999, 49(1):33-64.
[2] Kamangar F, Dores GM, Anderson WF, Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24(14):2137-2150.
[3] Pezzuto F, Buonaguro L, Caponigro F, et al. Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies[J]. Oncol, 2015, 89(1):125-136.
[4] 李子强, 白晓光, 杨志衡, 等. 姜黄素类化合物与生物活性研究进展[J]. 中国医药工业杂志, 2015, 46(3):305-311.
[5] 刘晓真, 张宏颖.姜黄素与肿瘤细胞作用的分子机制[J]. 大连医科大学学报, 2008, 30(5):465-468. LIU Xiaozhen, ZHANG Hongying. Molecularmechanism ofeffectofcurcuminontumor[J]. J Dalian Med Univ, 2008, 30(5):465-468.
[6] 黄珈雯.姜黄素的抗肿瘤作用研究进展[J]. 甘肃中医, 2008, 21(11):55-56.
[7] Fulda S, Debatin KM.Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol[J].Cancer Res, 2004,64(1):337-346.
[8] Proviciali M, Re F, Donnin A.Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice[J].Int J Cancer, 2005, 115(1):36-45.
[9] Leemans CR, Braakhuis BJ, Rrakenhoff RH, The molecular biology of head and neck cancer[J]. Nat Rev Cancer, 2011, 11(1):9-22.
[10] Borges GA, Rego DF, Assad DX, et al. In vivo and in vitro effects of curcumin on head and neck carcinoma: a systematic review[J]. J Oral Pathol Med, 2017, 46(1):3-20.
[11] Hu A, Huang JJ, Li RL, et al. Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1[J]. Sci Rep, 2015, 5:13429.
[12] Tyagi A, Gu M, Takahata T, et al. Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma[J]. Clin Cancer Res, 2011. 17(16):5402-5411.
[13] Piao L, Mukherjee S, Chang Q, et al. TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma[J]. Oncotarget, 2016,DOI: 10.18632/oncotarget.10620
[14] Dandawate PR, Subramaniam D, Jensen RA, et al.Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breastcancer therapy[J]. Semin Cancer Biol, 2016, 41:192-208.
[15] Ryu MJ, Cho M, Song JY, et al. Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300[J]. Biochem Biophys Res Commun, 2008, 377:1304-1308.
[16] Atten MJ, Godoy-Romero E, Attar BM, et al. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells[J]. Invest New Drugs, 2005, 23:111-119.
[17] Nonn L, Duong D, Peehl DM, et al. Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells[J]. Carcinogenesis, 2007, 28(6):1188-1196.
[18] Du Q, Hu B, An HM, et al. Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells[J]. Oncol Rep, 2013, 29(5):1851-1858.
[19] Suzuki O, Abe M. Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma [J]. Oncol Rep, 2008, 19(3):743-748.
[20] Takai N, Ueda T, Nishida M.Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells [J].Int J Mol Med, 2008, 21(1):109-115.
[21] Masuelli L, Di Stefano E, Fantini M. Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas[J]. Oncotarget, 2014, 5(21):10745-10762.
[22] Kiraz Y, Adan A, Kartal Yandim M. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumour Biol, 2016: 10.1007/s13277-016-5035-9
[23] Kumar S. Caspase function in programmed cell death[J]. Cell Death Differ, 2006, 14(1):32-43.
[24] 赵永强,冯慧伟,范献良,等.塞来昔布诱导喉癌Hep-2细胞凋亡的实验研究 [J]. 山东大学耳鼻喉眼学报, 2014,28(2):41-45. ZHAO Yongqiang, FENG Huiwei, FAN Xianliang, et al. Apoptosis of Hep-2 cells induced by celecoxib[J]. J Otolaryngol Ophthalmol Shandong Univ, 2014, 28(2):41-45.
[1] 吴敏,李正阳,孟杰,叶惠平. 程序性细胞死亡的分子机制和其在鼻咽癌中的作用[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 152-157.
[2] 许莞菁,孙雨浩,赵军. 姜黄素的抗氧化性对视网膜退行性疾病的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 146-151.
[3] 辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65.
[4] 吴翠萍,朱一丹,李春燕,殷善开. 胆红素对神经干细胞活性和增殖的影响研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 1-6.
[5] 付艺璇,王涛,曹静,李光达,郑凌方,许莞菁,赵爽. 羟基红花黄色素A对大鼠视网膜光损伤的保护作用[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 128-134.
[6] 颜繁诚,蒋现,柴一杰,王昊森,孟照洋,汪晓磊,王艳玲,冯雪. miR-30-5p通过下调FOXG1表达抑制视网膜母细胞瘤细胞增殖[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 63-69.
[7] 刘勇,袁存立,曹慧,郑成彩,晁方, 许风雷. CHD1L通过EMT促进喉鳞状细胞癌细胞的增殖、侵袭和转移[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 32-39.
[8] 张依,王文俊，杨安怀. SIRT1激动剂白藜芦醇在眼部疾病中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 151-156.
[9] 刘志高,王淑雅,韩旭光,王玉,李志伟,马爱华,赵博军. 增殖性糖尿病视网膜病变术前玻璃体腔应用阿柏西普的时机及其疗效观察[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 99-103.
[10] 黄泽雷,宋琦,路秀英,崔兰珍,李晓明. 双氢青蒿素对下咽癌Fadu细胞内质网应激途径的作用[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 31-35.
[11] 谢益,韩锋产. miRNAs与内耳发育和听觉毛细胞凋亡与再生的研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 126-129.
[12] 许莉,王志颐,陈伟,薛飞,张勇,程友,季俊峰,崔鹏程,江满杰. MicroRNA-24对人喉鳞癌细胞生物学行为的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 30-37.
[13] 李国彬,张占成,王新颜. 上调miR-200b对人喉癌Hep-2细胞增殖、迁移和侵袭能力的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 53-57.
[14] 苏杰,艾昕,马春梅,杨馥宇,黄帅. 急性高眼压大鼠外侧膝状体神经元细胞自噬与凋亡的关系[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 68-71.
[15] 赵小燕,吴彩琴,任晓勇,王正辉. 白花蛇舌草多糖提取物诱导Hep-2细胞凋亡与抑制侵袭机制[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 84-87.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发